Authors: Bone, H Williams, NA

Citation: H. Bone et Na. Williams, Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells, INT IMMUNOL, 13(6), 2001, pp. 807-816

Authors: Bone, H Welham, MJ

Citation: H. Bone et Mj. Welham, Shc associates with the IL-3 receptor beta subunit, SHIP and Gab2 following IL-3 stimulation: Contribution of Shc PTB and SH2 domains, CELL SIGNAL, 12(3), 2000, pp. 183-194

Authors: Greenspan, SL Harris, ST Bone, H Miller, PD Orwoll, ES Watts, NB Rosen, CJ

Citation: Sl. Greenspan et al., Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis, AM FAM PHYS, 61(9), 2000, pp. 2731-2736

Authors: Bone, H

Citation: H. Bone, Bone disease and malignancy, TREATMENT OF METABOLIC BONE DISEASE: MANAGEMENT STRATEGY AND DRUG THERAPY, 2000, pp. 57-74

Authors: McCloskey, EV Bone, H Rodan, G McClung, M Wallach, S Lyles, KW Grauer, A Mautelan, C Gutteridge, DH",Anderson,Hooper,Ralston,Sharpe,Posen

Citation: Ev. Mccloskey et al., Newer bisphosphonates in the treatment of Paget's disease of bone: Where we are and where we want to go - Discussion, J BONE MIN, 14, 1999, pp. 74-78